SCHEMBL14083963

SCHEMBL14083963

COc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)cn2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ TRPV1 Q8NER1 4/20 0.51
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ KEAP1 Q14145 1/20 0.49
▸ NFE2L2 Q16236 1/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ PABPC1 P11940 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.48
▸ MAPT P10636 1/20 0.48
▸ NAMPT P43490 1/20 0.48
▸ NPC1 O15118 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083510 0.89 TRPV1 (0.65) POLBSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL14083905 0.86 RAB9A (0.60) POLBSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL14083962 0.85 KCNQ3 (0.54) TRPV1RAB9AKDM4ENPC1
SCHEMBL14083930 0.83 GRM4 (0.62) SMN1; SMN2TRPV1MEN1KMT2ARAB9A
SCHEMBL14083936 0.83 GRM4 (0.66) SMN1; SMN2TRPV1MEN1KMT2ARAB9A
SCHEMBL14083998 0.83 KDM4E (0.62) SMN1; SMN2TRPV1RAB9AKDM4EMAPT
SCHEMBL14083365 0.83 TRPV1 (0.51) POLBSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL14083623 0.83 TRPV1 (0.52) POLBSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL14083221 0.83 POLB (0.48) POLBSMN1; SMN2TRPV1MEN1KMT2A
SCHEMBL14083914 0.82 TRPV1 (0.59) SMN1; SMN2TRPV1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 POLB 4543/4885SMN1; SMN2 2099/4885TRPV1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback